CALQUENCE® (acalabrutinib)

Learn more at US HCPs only.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

Please see Important Safety Information below and full Prescribing Information at https://t.co/cXeF3xbMJl.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@MilkDrunkUS @MilkDrunkUS Unfortunately, we do not have the answer to this question.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@Pig_then_ghost Hello, @Pig_then_ghost. We're sorry to hear about your experience. You should discuss all side effects of CALQUENCE with your doctor. We'd also like to hear more about your experience. Please call us at 1-800-236-9933.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

https://t.co/W83AqpUk5A Learn more about the demonstrated efficacy and safety profile of CALQUENCE.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@BeckyPritchard2 Twitter helps us deliver ads to people who may be interested. Although you can't
opt out of seeing ads entirely, you can hide certain personalized ads. Click here to learn more:
https://t.co/ltIeZggDWB

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@rwrgltx We're sorry to hear about your experience. This channel is intended for healthcare professionals. You should discuss all side effects of CALQUENCE with your doctor. We'd also like to hear more about your experience. Please call us at 1-800-236-9933.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

https://t.co/W83AqpUk5A CALQUENCE is for the treatment of Mantle Cell Lymphoma (MCL) in adult patients who have received at least one prior therapy.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@Kkh291 Hello. Please contact your insurance provider and/or pharmacist with questions about your coverage as plans may vary. If you have questions regarding access and reimbursement, you can call the Access360 program at [1-844-ASK-A360] or visit [https://t.co/4HtooHgdwd].

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

https://t.co/W83AqpUk5A In a study of 535 chronic lymphocytic leukemia (CLL) patients, 1L CALQUENCE+obinutuzumab demonstrated 90% relative risk reduction (HR=0.10[95% CI: 0.06-0.17], P<0.001) in disease progression or death vs GCIb (obinutuzumab+chlorambucil).

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@bck27 Twitter helps us deliver ads to people who may be interested. Although you can't
opt out of seeing ads entirely, you can hide certain personalized ads. Click here to learn more:
https://t.co/ltIeZggDWB

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@BrucePerens Twitter helps us deliver ads to people who may be interested. Although you can't
opt-out of seeing ads entirely, you can hide certain personalized ads. Click here to learn more:
https://t.co/ltIeZggDWB

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@ozkanayazoglu This channel is intended for healthcare professionals only. For more information on CALQUENCE and who it is indicated for, please visit https://t.co/WFFImTRysO.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@ozkanayazoglu For information about the cost of CALQUENCE, please contact one of our Patient Access Specialists at [1-844-ASK-A360 (1-844-275-2360)]. They're available Monday through Friday from 8 AM to 8 PM ET and will be happy to assist you.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@ElizabethBaret6 Twitter helps us deliver ads to people who may be interested. Although you can't
opt-out of seeing ads entirely, you can hide certain personalized ads. Click here to learn more:
https://t.co/ltIeZggDWB

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

https://t.co/W83AqpUk5A CALQUENCE is for the treatment of Mantle Cell Lymphoma (MCL) in adult patients who have received at least one prior therapy.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@engrtomi CALQUENCE is approved for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Learn more about CALQUENCE: https://t.co/qQ4yMIFTuk

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

https://t.co/W83AqpUk5A In a study of 535 chronic lymphocytic leukemia (CLL) patients, 1L CALQUENCE+obinutuzumab demonstrated 90% relative risk reduction (HR=0.10[95% CI: 0.06-0.17], P<0.001) in disease progression or death vs GCIb (obinutuzumab+chlorambucil).

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@Suzijul Learn about the safety profile and the common adverse reactions of CALQUENCE by visiting https://t.co/Etpo4xOcq3 for MCL safety information and https://t.co/Z2ZdsZzmk6 for CLL/SLL safety information.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

https://t.co/4yUlwscQKU Sign up for an engaging discussion with expert opinions on questions like these. Reserve your virtual seat here: https://t.co/dHk7ViaXdo

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@notsameucountry Twitter helps us deliver ads to people who may be interested. Although you can't opt-out of seeing ads entirely, you can hide certain personalized ads. Click here to learn more: https://t.co/ltIeZggDWB.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@SHE_RAH369 Hi. For more information and to find out if CALQUENCE is right for you, please talk to your doctor. You can also visit our website to learn more about CALQUENCE https://t.co/WFFImTRysO

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

https://t.co/4yUlwscQKU How do expert community oncologists approach patients with CLL? Join our live broadcast to find out.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@yeetyboii Twitter helps us deliver ads to people who may be interested. Although you can't
opt-out of seeing ads entirely, you can hide certain personalized ads. Click here to learn more:
https://t.co/ltIeZggDWB

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

CALQUENCE is for the treatment of Mantle Cell Lymphoma (MCL) in adult patients who have received at least one prior therapy. https://t.co/1CUkBFpERJ

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@DaveSmi57775265 For information about the cost of CALQUENCE, please contact one of our Patient Access Specialists at 1-844-ASK-A360 (1-844-275-2360). They're available Monday through Friday from 8 AM to 8 PM ET and will be happy to assist you.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@Kweatey We're sorry to hear about your experience. This channel is intended for healthcare professionals. You should discuss all side effects of CALQUENCE with your doctor. We'd also like to hear more about your experience. Please call us at 1-800-236-9933.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

CALQUENCE is for the treatment of Mantle Cell Lymphoma (MCL) in adult patients who have received at least one prior therapy. https://t.co/1CUkBFpERJ

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@JoelNickerson7 This channel is intended for healthcare professionals only. For more information on
CALQUENCE and who it is indicated for, please visit https://t.co/WFFImTRysO.

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

https://t.co/W83AqpUk5A In a study of 535 chronic lymphocytic leukemia (CLL) patients, 1L CALQUENCE+obinutuzumab demonstrated 90% relative risk reduction (HR=0.10[95% CI: 0.06-0.17], P<0.001) in disease progression or death vs GCIb (obinutuzumab+chlorambucil). #ASCO20

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

@parsifal CALQUENCE is approved for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Learn more about CALQUENCE: https://t.co/qQ4yMIFTuk

[CALQUENCE® (acalabrutinib) @CalquenceHCP]

CALQUENCE is now available for adult patients with Chronic Lymphocytic Leukemia (CLL). https://t.co/1CUkBFpERJ